GlassScriptPhysician profile
April M Kaiser
NPI 1235186545
$616.40
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $12.59 · 2023: $222 · 2024: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $168.45 | 2022-2023 | Seglentis, Livalo |
| Astrazeneca Pharmaceuticals LP | $127.18 | 2021-2024 | Farxiga, Airsupra |
| Amgen INC. | $79.02 | 2023-2024 | Krystexxa, Otezla, Repatha |
| Amarin Pharma, INC. | $77.26 | 2021 | |
| Pfizer INC. | $32.57 | 2024 | |
| Novo Nordisk INC | $32.16 | 2021-2024 | |
| Lilly USA, LLC | $26.22 | 2021 | |
| Seqirus USA INC | $19.51 | 2024 | Fluad, Flucelvax |
| Exact Sciences Corporation | $14.36 | 2023 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $13.41 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.19 | 2024 | |
| Medicomp INC | $13.07 | 2023 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.